Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease.
Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease.
复制标题
DOI:
10.1016/j.cellsig.2014.04.009
复制
发表时间:
2014-08
影响因子:
4.8
通讯作者:
Chen L
中科院分区:
文献类型:
--
作者:
Xu Y;Liu C;Chen S;Ye Y;Guo M;Ren Q;Liu L;Zhang H;Xu C;Zhou Q;Huang S;Chen L
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons. Dysregulation of mammalian target of rapamycin (mTOR) has been implicated in the pathogenesis of PD. However, the underlying mechanism is incompletely elucidated. Here, we show that PD mimetics (6-hydroxydopamine, N-methyl-4-phenylpyridine or rotenone) suppressed phosphorylation of mTOR, S6K1 and 4E-BP1, reduced cell viability, and activated caspase-3 and PARP in PC12 cells and primary neurons. Overexpression of wild-type mTOR or constitutively active S6K1, or downregulation of 4E-BP1 in PC12 cells partially prevented cell death in response to the PD toxins, revealing that mTOR-mediated S6K1 and 4E-BP1 pathways due to the PD toxins were inhibited, leading to neuronal cell death. Furthermore, we found that the inhibition of mTOR signaling contributing to neuronal cell death was attributed to suppression of Akt and activation of AMPK. This is supported by the findings that ectopic expression of constitutively active Akt or dominant negative AMPKα, or inhibition of AMPKα with compound C partially attenuated inhibition of phosphorylation of mTOR, S6K1 and 4E-BP1, activation of caspase-3, and neuronal cell death triggered by the PD toxins. The results indicate that PD stresses activate AMPK and inactivate Akt, causing neuronal cell death via inhibiting mTOR-mediated S6K1 and 4E-BP1 pathways. Our findings suggest that proper co-manipulation of AMPK/Akt/mTOR signaling may be a potential strategy for prevention and treatment of PD.
登录
查看更多内容
影响因子:
2.5
作者:
Chongthammakun, Vasutakarn;Sanvarinda, Yupin;Chongthammakun, Sukumal
通讯作者:
Chongthammakun, Sukumal
影响因子:
7.4
作者:
Chen, Long;Xu, Baoshan;Liu, Lei;Luo, Van;Zhou, Hongyu;Chen, Wenxing;Shen, Tao;Han, Xiuzhen;Kontos, Christopher D.;Huang, Shile
通讯作者:
Huang, Shile
影响因子:
4.6
作者:
Koppula S;Kumar H;Kim IS;Choi DK
通讯作者:
Choi DK
影响因子:
7.4
作者:
Chen, Long;Liu, Lei;Huang, Shile
通讯作者:
Huang, Shile
影响因子:
11.4
作者:
Imai, Yuzuru;Gehrke, Stephan;Lu, Bingwei
通讯作者:
Lu, Bingwei